Where others have failed will Atl1102 succeed ?, page-91

First I would like to say that my views are not intended to disparage those offered by others as I think diversity in viewpoints is the best way to make real progress, and also that I don't have any sources of information from within the company.

I note that the 23 April announcement was "authorized for release by the Board" which I take to mean is in conformity with the Boards collective view. Moreover,I think the Board members would have been very aware that the announcement marked Dr. Gittlesons' initial participation as a Board member and is about an extremely important meeting, and all of them would have been involved in the deliberations that were expressed in the CEO's final sentences.

Regarding ITSA's dismissal the of the TGA, I ask that you provide justification for holding that view. My view is that has been achieved so far is due to the TGA approving the trial with only nine boys to proceed - the results of which have been the basis for the EMU/FDA negotiations, and if the company had been in a position to request an extension of that trial for a further 6 months ATL1102 may now already be approved for sale in Australia by the TGA. You attended the last live AGM which was virtually devoted to self-congratulation for what had been achieved at the TGA trial.